Source: http://www.drugs.com/newdrugs.html
Drugs.com - New Drug Approvals
FDA Approves Ranexa for First Line Anti Anginal Use
Published in November 6th, 2008
PALO ALTO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new, first line indication for Ranexa (ranolazine extended-release tablets) for the treatment...
Source: http://www.drugs.com/newdrugs.html
Drugs.com - New Drug Approvals
Source: http://www.drugs.com/newdrugs.html
Drugs.com - New Drug Approvals
No user responded in " FDA Approves Ranexa for First Line Anti Anginal Use "
Subscribes to this post comment rss or trackback url